Furthermore, the presence of Tn/STn antigens in various solid tumors, including ovarian cancer, prostate cancer, and lung cancer, has been linked to poor clinical outcomes, highlighting their potential as diagnostic and therapeutic targets in cancer (33–35). This evidence concerns the gene EEF1A2 and cancer.